01/23/2014 - 2:18pm

High-fluoride toothpaste may help prevent white spots from braces, according to a Reuters report citing a new study from Sweden.

01/23/2014 - 2:11pm

Anoka-Ramsey Community College announced that it will offer an associate in science degree in Pharmacy Technician. The required general education courses for the new program can be taken at either the Cambridge or Coon Rapids locations.

01/23/2014 - 1:50pm

When selecting an exchange health plan under the Affordable Care Act, consumers should be able to evaluate plans’ success in medication management, among other quality measures, the National Association of Chain Drug Stores stated in comments to the Centers for Medicare and Medicaid Services.

01/23/2014 - 11:55am

Match.com and Pfizer announced results from a recent survey showing that single smokers may want to consider breaking up with their cigarettes as they look for that special someone this year.

01/23/2014 - 11:13am

Valeant Pharmaceuticals International on Thursday announced the expiration of the tender offer by a subsidiary of Valeant Pharmaceuticals International to purchase all of the outstanding shares of Solta Medical for $2.92 per share in cash, without interest (less any applicable withholding taxes).

01/23/2014 - 10:52am

For patients in the early stages of multiple sclerosis, low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to a new study led by the Harvard School of Public Health investigators in collaboration with Bayer HealthCare.

01/23/2014 - 10:43am

The global telehealth market is expected to grow as medical providers increasingly employ remote communications and monitoring technology to reduce costs and improve the quality of care, according to a report published by IHS Technology.

01/23/2014 - 10:18am

Assembly Member Richard Bloom, D-Santa Monica, introduced legislation that would authorize a pharmacist to dispense the narcotic antagonist naloxone hydrochloride without a prescription in California.

01/22/2014 - 1:16pm

Takeda Pharmaceuticals and Lundbeck announced the availability of Brintellix (vortioxetine), a once-daily oral antidepressant for treatment of major depressive disorder in adults.